Imidazole → HCID 11312070, compound
Reaction equation
[CH2:1]([Si:3](Cl)([CH2:6][CH3:7])[CH2:4][CH3:5])[CH3:2].N1C=CN=C1.[O:14]1[CH:18]=[CH:17][CH:16]=[C:15]1[C@@H:19]1[NH:22][C:21](=[O:23])[C@@:20]1([OH:25])[CH3:24].C(OCC)(=O)C.CCCCC>CN(C=O)C>[O:14]1[CH:18]=[CH:17][CH:16]=[C:15]1[C@@H:19]1[NH:22][C:21](=[O:23])[C@@:20]1([O:25][Si:3]([CH2:6][CH3:7])([CH2:4][CH3:5])[CH2:1][CH3:2])[CH3:24]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Triethyl silyl chloride (0.316 g, 2.1 mmol) and imidazole (0.100 g, 1.5 mmol) were added to a stirred solution of (3R,4R)-4-(furan-2-yl)-3-hydroxy-3-methyl-azetidin-2-one (0.167 g, 1.0 mmol) in DMF (6.0 ml) at 25° C. under argon atmosphere. The reaction solution was quenched after 4 h with a saturated NH4Cl aqueous solution and extracted with ethyl acetate. The organic phase was dried and concentrated under reduced pressure. Chromatography of the residue (SiO2, ethyl acetate/n-pentane, 1:2) afforded 0.190 g (0.67 mmol 67%) of (3R,4S)-4-(furan-2-yl)-3-triethylsilyloxy-3-methyl-azetidin-2-one: [α]D20=+42.8 (c 1.04, CHCl3); IR (CDCl3, cm−1): 3600–3000, 3413, 2957, 1768, 1458, 1377, 1012; 1H NMR (CDCl3): δ=0.65 (m, 6H, 3 CH2), 0.95 (t, 9H, 3 Me), 1.19 (s, 3H, Me), 4.54 (s, 1H), 6.27 (d, 1H, 2-furyl), 6.28 (m, 1H, 2-furyl), 6.72 (b, 1H, NH), 7.40 (m, 1H, 2-furyl); 13H NMR (CDCl3): δ=5.71 (CH2), 6.73 (Me), 19.3 (Me), 61.0 (CH), 89.1(C), 108.1 (CH), 110.5 (CH), 142.7 (CH), 150.9 (C), 171.5 (C).
Workup
- customThe reaction solution was quenched after 4 h with a saturated NH4Cl aqueous solution
- extractionextracted with ethyl acetate
- customThe organic phase was dried
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-75f2a2a648b643108d73a0fe9643c5e6
- Source dataset
- uspto-grants-2006_12
- Patent number
- US07153884B2
Reaction notes
Loading…